Lisinopril and Hydrochlorothiazide
- Product NDC
- 50090-1219
- 11-digit product format
- 500901219
- Labeler code
- 50090
- Product ID
- 50090-1219_4f4c3e61-c167-4c37-bc6d-a80e0eee08ce
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA076194
- Marketing category
- ANDA
- Marketing start
- 2003-03-04
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL; HYDROCHLOROTHIAZIDE
- Active strength
- 20 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-1219-0 | 50090121900 | 30 TABLET in 1 BOTTLE (50090-1219-0) | 30 tablet | 2014-11-28 | 0000-00-00 | No | No | Current |
| 50090-1219-1 | 50090121901 | 100 TABLET in 1 BOTTLE (50090-1219-1) | 100 tablet | 2014-11-28 | 0000-00-00 | No | No | Current |
| 50090-1219-2 | 50090121902 | 90 TABLET in 1 BOTTLE (50090-1219-2) | 90 tablet | 2014-11-28 | 0000-00-00 | No | No | Current |